Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration

Authors not listed

Kathryn Starr · 2025

Abstract

Age-related macular degeneration (AMD) is the primary cause of vision loss in people over the age of 55. Currently, no cure is available for individuals suffering from AMD. The purpose of this pilot study is to evaluate the feasibility of implementing a 5-month egg intervention in adults with intermediate AMD. The objective of this research study is to evaluate the feasibility of a whole egg (2 or 4 per day) intervention in older adults with intermediate AMD. The secondary objective of this research is to determine descriptive statistics, change over time and estimate effect sizes for retinal sensitivity, and vision, cognition and physical function. By completing these research objectives, the researchers hope to gain preliminary evidence in support of a larger trial that will assess the impact of egg consumption on eye health in adults with AMD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2025). Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration. <em>Kathryn Starr</em>. https://clinicaltrials.gov/study/NCT07021027
Vancouver
Anonymous. Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration. Kathryn Starr. 2025.
BibTeX
@misc{anon2025Feasib, title = {Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration}, author = {Anonymous}, journal = {Kathryn Starr}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings